Show simple item record

Authordc.contributor.authorDel Canto, Felipe 
Authordc.contributor.authorSierralta, Walter 
Authordc.contributor.authorKohen Skop, Paulina 
Authordc.contributor.authorFerrada Muñoz, Alex Eduardo 
Authordc.contributor.authorStrauss, Jerome F. 
Authordc.contributor.authorDevoto, Luigi 
Admission datedc.date.accessioned2019-03-11T12:54:57Z
Available datedc.date.available2019-03-11T12:54:57Z
Publication datedc.date.issued2007
Cita de ítemdc.identifier.citationJournal of Clinical Endocrinology and Metabolism, Volumen 92, Issue 11, 2018, Pages 4436-4443
Identifierdc.identifier.issn0021972X
Identifierdc.identifier.issn0021972X
Identifierdc.identifier.other10.1210/jc.2007-0125
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/164416
Abstractdc.description.abstractContext: The natural process of luteolysis and luteal regression is induced by withdrawal of gonadotropin support. Objective: The objectives of this study were: 1) to compare the functional changes and apoptotic features of natural human luteal regression and induced luteal regression; 2) to define the ultrastructural characteristics of the corpus luteum at the time of natural luteal regression and induced luteal regression; and 3) to examine the effect of human chorionic gonadotropin (hCG) on the steroidogenic response and apoptotic markers within the regressing corpus luteum. Design: Twenty-three women with normal menstrual cycles undergoing tubal ligation donated corpus luteum at specific stages in the luteal phase. Some women received a GnRH antagonist prior to collection of corpus luteum, others received an injection of hCG with or without prior treatment with a GnRH antagonist. Main Outcome Measure: Main outcome measures were plasma hormone levels and analysis of excised luteal t
Lenguagedc.language.isoen
Publisherdc.publisherEndocrine Society
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceJournal of Clinical Endocrinology and Metabolism
Keywordsdc.subjectEndocrinology, Diabetes and Metabolism
Keywordsdc.subjectBiochemistry
Keywordsdc.subjectEndocrinology
Keywordsdc.subjectClinical Biochemistry
Keywordsdc.subjectBiochemistry (medical)
Títulodc.titleFeatures of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin
Document typedc.typeArtículo de revista
dcterms.accessRightsdcterms.accessRightsAcceso Abierto
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile